Mika Scheinin
MD, PhD, Professor Emeritus
Bioanalytics; Clinical Pharmacology; Drug Development; Positron Emission Tomography; Research Ethics
- Väärät välittäjäaineet (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
- Vapautuneen noradrenaliinin inaktivaatio – soluunotto (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
- Adrenergisten reseptorien agonistit (sympatomimeetit) (2018) Farmakologia ja toksikologia Scheinin. Mika
- Alzheimerin taudin lääkekehityksen strategiat (2018)
- Duodecim
- Effect of oral KETOPROFEN treatment in acute respiratory disease outbreaks in finishing pigs (2018)
- Porcine Health Management
- Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model (2018)
- Veterinary Journal
- Effects of the peripherally acting alpha(2)-adrenoceptor antagonist MK-467 on cardiopulmonary function in sheep sedated by intramuscular administration of medetomidine and ketamine and reversed by intramuscular administration of atipamezole (2018)
- American Journal of Veterinary Research
- Increased Energy Expenditure, Lipolysis and Hyperinsulinemia Confer Resistance to Central Obesity and Type 2 Diabetes in Mice Lacking Alpha2α-Adrenoceptors (2018)
- Neuroendocrinology
- Lääkeaineiden sitoutuminen reseptoriin (2018) Farmakologia ja toksikologia Scheinin M
- Lääkeaineiden vaikutusmekanismit: reseptorit (2018) Farmakologia ja toksikologia Scheinin. Mika



